Totally Plc

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00BYM1JJ00
GBP
0.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Totally Plc stock-summary
stock-summary
Totally Plc
Pharmaceuticals & Biotechnology
Totally PLC is a holding company. The Company is engaged in the provision of solutions to the healthcare sector. Its segments include Innovative Solutions to the healthcare sector and Head Office Costs. The Innovative Solutions to the healthcare sector segment represents the operations of Totally Health Limited (Totally Health). The Head Office costs segment represents central costs that are offset by internal cost recoveries. Totally Health provides personalized Clinical Health Coaching to support patients with long term health conditions, and manages outcomes and healthcare costs. The Company offers My Clinical Coach, a direct-to-consumer health coaching service for people with long-term health conditions. The Company's subsidiary, Premier Physical Healthcare Limited, provides a range of treatments and advice for musculoskeletal injuries and conditions. The Company's subsidiary, About Health Limited, provides community-based health services.
Company Coordinates stock-summary
Company Details
Cardinal Square, West, 10 Nottingham Road DERBY None : DE1 3QT
stock-summary
Tel: 44 20 38663330
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 6 Foreign Institutions (27.26%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Robert Holt
Independent Non-Executive Chairman of the Board
Ms. Wendy Lawrence
Chief Executive Officer, Executive Director
Ms. Lisa Barter-Ng
Finance Director, Executive Director
Ms. Gloria Cooke
Clinical Quality Director, Executive Director
Mr. Anthony Bourne
Non-Executive Independent Director
Mr. Michael Rogers
Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

GBP 0 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.05

stock-summary
Return on Equity

-2.43%

stock-summary
Price to Book

0.01